Smith Beth Ann bought MGNX
February 15, 2025 · Form 4 insider transaction
Smith Beth Ann bought 1,095 shares of MacroGenics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,095
Price
$0.00
Total value
N/A
InsiderSmith Beth Ann
Role—
CompanyMacroGenics, Inc. (MGNX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 15, 2025
Filing dateFebruary 19, 2025
Shares owned after9,955
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.